Stephen T. Worland - 15 Nov 2023 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Issuer symbol
EFTR on OTC
Transactions as of
15 Nov 2023
Net transactions value
+$2,973
Form type
4
Filing time
16 Nov 2023, 17:30:08 UTC
Previous filing
14 Aug 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2,973 +5,979 +2.3% $0.4973 267,204 15 Nov 2023 Direct F1
holding EFTR Common Stock 562,339 15 Nov 2023 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.